サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655473

フィブリンシーラントの世界市場

Fibrin Sealants

出版日
ページ情報
英文 92 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
フィブリンシーラントの世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フィブリンシーラントの世界市場は2030年までに16億米ドルに達する

2024年に11億米ドルと推定されるフィブリンシーラントの世界市場は、2024年から2030年にかけてCAGR 6.1%で成長し、2030年には16億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるフィブリンシーラント液は、CAGR 6.4%を記録し、分析期間終了時には12億米ドルに達すると予測されます。フィブリンシーラントパッチセグメントの成長率は、分析期間中CAGR 5.4％と推定されます。

米国市場は2億9,310万米ドルと推定、中国はCAGR9.1％で成長予測

米国のフィブリンシーラント市場は、2024年に2億9,310万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを9.1%として、2030年までに3億6,410万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と5.9％と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界のフィブリンシーラント市場- 主要動向と促進要因のまとめ

フィブリンシーラントとは何か、なぜ医療アプリケーションに不可欠なのか？

フィブリンシーラントは、創傷治癒や組織修復を促進するために、様々な医療用途に使用される生物学的接着剤の一種です。フィブリノーゲンとトロンビンから構成されるこのシーラントは、血液凝固過程の最終段階を模倣し、傷を効果的に密閉し止血を促進するフィブリン塊の形成を促進します。フィブリンシーラントは、一般外科、整形外科、脳神経外科、心臓血管外科など、幅広い外科手術に使用されています。組織表面に接着し、出血を抑え、治癒を促進するその能力は、外科医やヘルスケア専門家にとって貴重なツールとなっています。

医療現場におけるフィブリンシーラントの重要性は、その接着性にとどまりません。フィブリンシーラントは、出血を管理し、組織の治癒を促進するための低侵襲なソリューションを提供し、特定の処置における従来の縫合糸やステープルの必要性を低減します。さらに、フィブリンシーラントは、抗生物質や成長因子などの治療薬を創傷部位に直接届けることができ、その効果をさらに高めます。高度な創傷治療や手術ソリューションへの需要が高まり続ける中、患者の転帰や手術効率を向上させるフィブリンシーラントの役割は、ますます認識されるようになってきています。

フィブリンシーラントの主な用途とヘルスケアのニーズとは？

フィブリンシーラントは様々な医療分野において、医療従事者や患者様のニーズに合わせて幅広く活用されています。一般外科では、フィブリンシーラントは肝切除、胃切除、大腸切除などの手術中の出血をコントロールするために一般的に使用されています。迅速な止血が可能なため、出血量を減らし、合併症のリスクを減らし、最終的に手術成績を向上させることができます。また、フィブリンシーラントをこれらの用途に使用することで、回復時間を延ばし、術後の痛みを最小限に抑えることができ、患者とヘルスケア施設の双方に利益をもたらします。

整形外科手術において、フィブリンシーラントは組織の治癒をサポートし、人工関節置換術、靭帯修復術、骨折固定術などの手術後の合併症のリスクを軽減するために使用されます。フィブリンシーラントは、組織の接着を促進し、治癒プロセスを向上させることにより、患者の早期回復と機能的転帰の改善に貢献します。外科医が手術結果を最適化するための効果的な解決策を求める中、筋骨格系の損傷管理への応用はますます一般的になってきています。

脳神経外科も、フィブリンシーラントが人気を集めている分野です。これらの製品は、出血のコントロールが重要な頭蓋や脊椎の手術中の出血管理に使用されています。フィブリンシーラントの生体適合性と粘着特性は、デリケートな手術環境での使用に理想的で、周辺組織を損なうことなく、出血を効果的に管理することができます。脳神経外科手術技術の進歩に伴い、フィブリンシーラントの採用は増加することが予想されます。

フィブリンシーラントは心臓血管外科、特に心臓バイパス術や弁置換術にも使用されています。フィブリンシーラントは、従来の縫合では困難であった部分でも効果的な止血を行い、手術の精度を高め、術後出血のリスクを軽減します。低侵襲心臓血管手術の需要の高まりは、創傷閉鎖と治癒を効果的に促進するフィブリンシーラントのような革新的なソリューションの必要性をさらに高めています。

さらに、フィブリンシーラントは創傷治療や組織工学などの新たな応用分野でも研究されています。フィブリンシーラントは、組織再生のためのサポート環境を提供することで、治療が困難な創傷の治癒を促進することができるため、慢性創傷管理への応用が注目されています。研究が進むにつれて新たな用途が発見され、ヘルスケア産業におけるフィブリンシーラントの可能性は拡大し、より幅広い医療ニーズに応えていくことでしょう。

技術の進歩はフィブリンシーラント市場にどのような影響を与えているか？

技術の進歩は、製品処方の改善、適用技術の向上、臨床使用の拡大により、フィブリンシーラント市場に大きな影響を与えています。特筆すべき開発のひとつに、フィブリンシーラント製剤の技術革新があり、性能や使い勝手の向上を目指しています。メーカー各社は、粘度と流動特性を最適化したフィブリンシーラントの創製に注力しており、より容易な塗布と組織表面への接着性の向上を可能にしています。このような進歩により、フィブリンシーラントは外科医にとってより使いやすくなり、様々な外科手術に採用されるようになってきています。

さらに、新しいデリバリーシステムの調査により、フィブリンシーラントの潜在的な用途が広がっています。スプレーアプリケーターやその他の高度な送達方法の開発により、フィブリンシーラントの正確で的を絞った適用が可能となり、様々な臨床現場での有効性が向上しています。このようなデリバリーイノベーションにより、ヘルスケアプロバイダーはフィブリンシーラントをより幅広い処置に使用することができ、最適な性能と結果を保証することができます。

フィブリンシーラント製剤への生体適合性および生物活性成分の統合は、市場に影響を与えるもう一つの動向です。メーカーは、成長因子、抗菌剤、その他の治療用添加剤をフィブリンシーラントに組み込んで治癒特性を高めることを模索しています。これらの進歩は、組織の再生を促進し、感染のリスクを低減することによって、患者の転帰を改善することを目的としています。このような機能強化の利点が解明されつつあることから、多機能性フィブリンシーラントの需要は拡大すると予想されます。

さらに、低侵襲手術技術の台頭がフィブリンシーラント市場に影響を与えています。外科医がより低侵襲な手技を採用するようになり、これらの手技に対応した効果的な創傷閉鎖ソリューションのニーズが高まっています。フィブリンシーラントは、従来の縫合糸を使用することなく、止血と治癒を促進するための適切な選択肢を提供するため、低侵襲手術で好まれています。

フィブリンシーラント市場は、患者の安全性と規制遵守の重視も技術革新の原動力となっています。メーカー各社は、製品が最高の安全性と有効性基準を満たすよう、調査と試験に投資しています。臨床効果と安全性が実証されたフィブリンシーラントの開発に注力することは、ヘルスケアプロバイダーや規制機関に受け入れられるために不可欠です。このような品質と安全性へのこだわりは、医療界におけるフィブリンシーラントの評価を高めると期待されています。

フィブリンシーラント市場の成長の原動力は？

フィブリンシーラント市場の成長は、外科手術の増加、高度な創傷ケアソリューションに対する需要の高まり、術後合併症の最小化への注力など、いくつかの重要な要因によって牽引されています。主な要因の1つは、世界の外科手術件数の増加です。ヘルスケア産業が拡大を続ける中、効果的な止血剤と創傷閉鎖ソリューションの需要が増加しています。フィブリンシーラントは、出血を抑制し治癒を促進するための効果的な選択肢を提供するもので、さまざまな外科専門分野で不可欠なものとなっています。

高度な創傷治療ソリューションに対する需要の高まりも、市場成長の重要な要因です。慢性創傷、褥瘡、手術部位感染などの増加に伴い、ヘルスケアプロバイダーは創傷治癒を促進し合併症を減らす革新的なアプローチを求めています。組織の修復をサポートし、感染リスクを低減する機能を持つフィブリンシーラントは、創傷管理でますます普及しています。患者の安全性と臨床転帰の向上が重視され、効果的な創傷ケア製品への需要がさらに高まっています。

さらに、術後の合併症を最小限に抑え、回復時間を延ばすことが重視されていることも、フィブリンシーラント市場に影響を与えています。ヘルスケアプロバイダーは、フィブリンシーラントを使用することで、出血を抑え、治癒を促進し、追加の介入の必要性を最小限に抑えることができるという特典を認識しています。病院や外科センターが患者の転帰と効率を優先するにつれ、外科診療におけるフィブリンシーラントの採用は拡大すると予想されます。

さらに、手術手技や技術の進歩は、フィブリンシーラントを日常的な外科診療に組み込むことを容易にしています。低侵襲手術が普及するにつれ、このような技術に対応した効果的な創傷閉鎖ソリューションの必要性がますます高まっています。フィブリンシーラントは、従来の縫合糸を使用することなく、止血と治癒を促進するための適切な選択肢を提供し、様々な外科専門分野での使用拡大に貢献しています。

最後に、様々な用途におけるフィブリンシーラントの有効性を調査している現在進行中の調査と臨床研究が、市場成長の原動力となっています。様々な外科手術におけるフィブリンシーラントの利点に関する新たなエビデンスが現れるにつれ、ヘルスケアプロバイダーはこれらの製品を診療に取り入れる可能性が高いです。フィブリンシーラントの使用を支持する臨床データの拡大は、医療界におけるフィブリンシーラントの受け入れと利用を促進すると思われます。

結論として、フィブリンシーラント市場は、外科手術の増加、高度な創傷ケアソリューションに対する需要の高まり、術後合併症の最小化に注力することにより、大きく成長する見込みです。製品の処方や送達方法における技術の進歩は、市場の可能性をさらに高めると思われます。ヘルスケアプロバイダーが患者の安全性と効果的な創傷管理を優先し続ける中、フィブリンシーラントの需要は今後数年で拡大すると予想されます。

セグメント

タイプ（液体、パッチ）;用途（心臓血管外科、整形外科、一般外科、移植外科、その他用途）;最終用途（病院、専門クリニック、その他最終用途）

調査対象企業の例（注目の36社）

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17257

Global Fibrin Sealants Market to Reach US$1.6 Billion by 2030

The global market for Fibrin Sealants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Fibrin Sealant Patches segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$293.1 Million While China is Forecast to Grow at 9.1% CAGR

The Fibrin Sealants market in the U.S. is estimated at US$293.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$364.1 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Fibrin Sealants Market – Key Trends & Drivers Summarized

What Are Fibrin Sealants, And Why Are They Essential in Medical Applications?

Fibrin sealants are a type of biological adhesive used in various medical applications to promote wound healing and tissue repair. Composed of fibrinogen and thrombin, these sealants mimic the final stages of the blood coagulation process, facilitating the formation of a fibrin clot that effectively seals wounds and enhances hemostasis. Fibrin sealants are used in a wide range of surgical procedures, including general surgery, orthopedics, neurosurgery, and cardiovascular surgery. Their ability to adhere to tissue surfaces, control bleeding, and accelerate healing makes them a valuable tool for surgeons and healthcare professionals.

The significance of fibrin sealants in medical practice extends beyond their adhesive properties. They provide a minimally invasive solution for managing bleeding and promoting tissue healing, reducing the need for traditional sutures and staples in certain procedures. Additionally, fibrin sealants can deliver therapeutic agents, such as antibiotics or growth factors, directly to the wound site, further enhancing their effectiveness. As the demand for advanced wound care and surgical solutions continues to rise, the role of fibrin sealants in improving patient outcomes and surgical efficiency is increasingly recognized.

What Are the Main Applications of Fibrin Sealants, And How Do They Cater to Healthcare Needs?

Fibrin sealants have a wide range of applications across various medical fields, catering to the specific needs of healthcare providers and patients. In general surgery, fibrin sealants are commonly used to control bleeding during procedures such as liver resections, gastric surgeries, and colorectal surgeries. Their ability to provide rapid hemostasis helps reduce blood loss and the risk of complications, ultimately improving surgical outcomes. The use of fibrin sealants in these applications also enhances recovery times and minimizes postoperative pain, benefiting both patients and healthcare facilities.

In orthopedic surgery, fibrin sealants are employed to support tissue healing and reduce the risk of complications following procedures such as joint replacements, ligament repairs, and fracture fixations. By promoting the adhesion of tissues and enhancing the healing process, fibrin sealants contribute to faster recovery and improved functional outcomes for patients. Their application in managing musculoskeletal injuries is becoming increasingly common as surgeons seek effective solutions to optimize surgical results.

Neurosurgery is another area where fibrin sealants are gaining traction. They are used to manage bleeding during cranial and spinal procedures, where controlling hemorrhage is critical. The biocompatibility and adhesive properties of fibrin sealants make them ideal for use in delicate surgical environments, ensuring that bleeding is effectively managed without compromising surrounding tissues. As advancements in neurosurgical techniques continue, the adoption of fibrin sealants is expected to increase.

Fibrin sealants are also used in cardiovascular surgery, particularly in procedures involving cardiac bypass and valve replacement. They provide effective hemostasis in areas where traditional sutures may be challenging to apply, enhancing surgical precision and reducing the risk of postoperative bleeding. The growing demand for minimally invasive cardiovascular procedures is further driving the need for innovative solutions like fibrin sealants that promote effective wound closure and healing.

Furthermore, fibrin sealants are being explored in emerging applications, such as wound care and tissue engineering. Their use in chronic wound management is gaining attention, as they can enhance healing in difficult-to-treat wounds by providing a supportive environment for tissue regeneration. As research continues to uncover new applications, the potential for fibrin sealants in the healthcare industry will likely expand, catering to a broader range of medical needs.

How Are Technological Advancements Impacting the Fibrin Sealants Market?

Technological advancements are significantly influencing the fibrin sealants market by improving product formulations, enhancing application techniques, and expanding their clinical use. One notable development is the innovation in fibrin sealant formulations, which aim to enhance their performance and usability. Manufacturers are focusing on creating fibrin sealants with optimized viscosity and flow characteristics, enabling easier application and improved adhesion to tissue surfaces. These advancements make fibrin sealants more user-friendly for surgeons, contributing to their growing adoption in various surgical procedures.

Additionally, research into novel delivery systems is expanding the potential applications of fibrin sealants. The development of spray applicators and other advanced delivery methods allows for precise and targeted application of fibrin sealants, improving their effectiveness in diverse clinical settings. These delivery innovations enable healthcare providers to use fibrin sealants in a broader range of procedures, ensuring optimal performance and outcomes.

The integration of biocompatible and bioactive components into fibrin sealant formulations is another trend impacting the market. Manufacturers are exploring the incorporation of growth factors, antimicrobial agents, and other therapeutic additives into fibrin sealants to enhance their healing properties. These advancements are aimed at improving patient outcomes by promoting tissue regeneration and reducing the risk of infection. As research continues to uncover the benefits of these enhancements, the demand for multifunctional fibrin sealants is expected to grow.

Moreover, the rise of minimally invasive surgical techniques is influencing the fibrin sealants market. As surgeons increasingly adopt less invasive approaches to procedures, the need for effective wound closure solutions that align with these techniques is rising. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, making them a preferred choice in minimally invasive surgeries.

The emphasis on patient safety and regulatory compliance is also driving innovation in the fibrin sealants market. Manufacturers are investing in research and testing to ensure that their products meet the highest safety and efficacy standards. The focus on developing fibrin sealants with proven clinical benefits and safety profiles is essential for gaining acceptance among healthcare providers and regulatory bodies. This commitment to quality and safety is expected to enhance the reputation of fibrin sealants in the medical community.

What Is Driving the Growth in the Fibrin Sealants Market?

The growth in the fibrin sealants market is driven by several key factors, including increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. One of the primary drivers is the growing number of surgical procedures performed globally. As the healthcare industry continues to expand, the demand for effective hemostatic agents and wound closure solutions is increasing. Fibrin sealants provide an effective option for controlling bleeding and promoting healing, making them essential in various surgical specialties.

The rising demand for advanced wound care solutions is another significant factor contributing to market growth. With an increasing prevalence of chronic wounds, pressure ulcers, and surgical site infections, healthcare providers are seeking innovative approaches to enhance wound healing and reduce complications. Fibrin sealants, with their ability to support tissue repair and reduce infection risks, are becoming increasingly popular in wound management. The ongoing emphasis on patient safety and improved clinical outcomes is further driving the demand for effective wound care products.

Additionally, the focus on minimizing postoperative complications and enhancing recovery times is influencing the fibrin sealants market. Healthcare providers are recognizing the benefits of using fibrin sealants in reducing bleeding, promoting healing, and minimizing the need for additional interventions. As hospitals and surgical centers prioritize patient outcomes and efficiency, the adoption of fibrin sealants in surgical practice is expected to grow.

Moreover, advancements in surgical techniques and technology are facilitating the integration of fibrin sealants into routine surgical practice. As minimally invasive procedures gain popularity, the need for effective wound closure solutions that align with these techniques becomes increasingly important. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, contributing to their growing use in various surgical specialties.

Finally, ongoing research and clinical studies investigating the efficacy of fibrin sealants in different applications are driving market growth. As new evidence emerges regarding the benefits of fibrin sealants in various surgical procedures, healthcare providers are likely to incorporate these products into their practice. The expanding body of clinical data supporting the use of fibrin sealants will enhance their acceptance and utilization in the medical community.

In conclusion, the fibrin sealants market is poised for significant growth driven by increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. Technological advancements in product formulations and delivery methods will further enhance the market's potential. As healthcare providers continue to prioritize patient safety and effective wound management, the demand for fibrin sealants is expected to flourish in the coming years.

SCOPE OF STUDY:

The report analyzes the Fibrin Sealants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Liquid, Patches); Application (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery, Other Applications); End-Use (Hospitals, Specialty Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Fibrin Sealants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Adoption of Fibrin Sealants in Hemostasis and Wound Healing Expands Addressable Market
    • Surge in Demand for Fibrin Sealants in Minimally Invasive Surgeries Fuels Market Growth
    • Growing Focus on Fibrin Sealants for Reducing Blood Loss and Postoperative Complications Strengthens Business Case
    • Surge in Adoption of Fibrin Sealants in Orthopedic and Trauma Surgeries Expands Market Opportunities
    • Growing Demand for Fibrin Sealants in Dental and Maxillofacial Surgeries Expands Addressable Market
    • Surge in Adoption of Fibrin Sealants in Plastic and Reconstructive Surgeries Expands Market Opportunities
    • Technological Advancements in Fibrin Sealants for Enhanced Biocompatibility Propel Market Growth
    • Growing Use of Fibrin Sealants in Neurosurgery and Spinal Procedures Strengthens Business Case
    • Rising Adoption of Fibrin Sealants in Emerging Markets with Expanding Healthcare Infrastructure Sets the Stage for Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Cardiovascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Transplant Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Fibrin Sealants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION